Fmc Corp Stock Price, News & Analysis

FMC Corporation (NYSE: FMC) has announced a definitive agreement to acquire Denmark-based BioPhero ApS for approximately $200 million. This acquisition adds advanced pheromone technology to FMC's product portfolio, with expectations of generating around $1 billion in revenue from pheromone products by 2030. BioPhero's innovative fermentation process lowers production costs, expanding market accessibility beyond specialty crops. FMC aims to launch five new pheromone products within the next three to five years, reinforcing its commitment to sustainable agriculture.

FMC Corporation has introduced a new brand identity for its Plant Health business, emphasizing its growth in the biologicals sector.

This year, FMC will launch two new products: Zironar™ biofungicide/bionematicide in the U.S. and Provilar™ biofungicide in Brazil, aimed at enhancing crop protection and yield.

FMC's biologicals platform includes over 50 products, supported by substantial R&D investments. The company anticipates launching four new biopesticides globally over the next four years, reinforcing its commitment to sustainable agriculture.

FMC Corporation (NYSE: FMC) will release its second quarter 2022 earnings on August 2, 2022, after market close. The results will be available through PR Newswire and on the company's website. A webcast conference call is scheduled for August 3, 2022, at 9:00 a.m. ET. The call can be accessed via internet and telephone for public participation. Additionally, a replay will be available from August 3, 2022, to August 24, 2022. The company focuses on agricultural sciences and innovative crop protection solutions.

FMC Corporation (NYSE: FMC) has been awarded the Responsible Care Company of the Year by the American Chemistry Council (ACC), marking the fourth time since 2017 it has received this honor. The award recognizes FMC's exceptional performance in environmental, health, safety, and security (EHS&S). The company achieved a record-low recordable injury rate of 0.066 in 2021, reflecting its strong safety culture. FMC has committed to net-zero greenhouse gas emissions by 2035, emphasizing sustainability in its operations and community responsibility.

FMC Corporation has been awarded the Best Biostimulant Product at the 2022 World BioProtection Awards for its Accudo® biostimulant. This accolade, presented at the World BioProtection Summit in Birmingham, UK, highlights the biostimulant's significant advantages in crop protection. Accudo® has shown a yield increase of over 15% and improves crop vigor and development, especially under stressful conditions. Available in South Korea, Greece, Turkey, and Germany, this recognition underscores FMC's commitment to innovative agricultural solutions.

FMC Corporation (NYSE: FMC) has announced the departure of Bethwyn Todd, president of FMC Asia Pacific, due to health reasons. Pramod Thota, former president of FMC U.S.A., will succeed her as president of the Asia Pacific region, effective July 1. During her tenure, Todd significantly increased revenue, market share, and profitability in the Asia Pacific. Thota brings extensive experience from his roles at FMC, including leadership in FMC India. The leadership transition aims to ensure continuity and leverage Thota's insights in this rapidly growing market.

FMC Corporation (NYSE: FMC) announced a significant legal victory on May 10, 2022, as the Ningbo Intermediate People's Court in Zhejiang Province, China, granted a preliminary injunction against Zhejiang Yongtai Technology Co. Ltd. This injunction prevents Yongtai from selling chlorantraniliprole, FMC's flagship insecticide, until the patent expires. This ruling is notable as it marks one of the rare instances of pre-suit injunctions being issued under China Patent Law. FMC emphasizes the importance of intellectual property in fostering innovation in the Chinese market.

FMC Corporation (NYSE: FMC) has filed a patent infringement lawsuit against Aceto US, LLC in the U.S. District Court for Delaware, alleging unauthorized use of FMC's patented insecticide ingredient, chlorantraniliprole. The lawsuit claims Aceto received chlorantraniliprole shipments from suppliers in India and China, infringing FMC's intellectual property rights. FMC seeks damages and an injunction to prevent further infringement, emphasizing its commitment to protecting its research investments in crop protection technologies.